πΆ Retinopathy of Prematurity (ROP) is a vasoproliferative disorder of the developing retina seen in preterm, low birth weight infants.
It results from arrested normal retinal vascularisation followed by abnormal vessel growth β fibrosis β tractional retinal detachment β blindness.
π About
- Retinal vessels grow from the optic disc towards the ora serrata.
- Reach nasal ora serrata at ~36 weeks, temporal ora serrata at ~40 weeks.
- ROP arises if this process is arrested β typically <32 weeks gestation.
𧬠Aetiology & Risk Factors
- Hyperoxia (often iatrogenic, from Oβ therapy for neonatal RDS) β β growth factor production β arrested vascular growth.
- Hypoxia of peripheral retina (as it becomes metabolically active) β VEGF surge β abnormal neovascularisation.
- Risk factors:
- Prematurity (<28 weeks).
- Birth weight <1500 g.
- Neonatal hyperglycaemia, sepsis, transfusions.
- Fluctuating oxygen saturations (esp. with poor NICU control).
π©Ί Clinical Features (Exam)
- White demarcation line separating vascular vs. avascular retina.
- Abnormal, dilated, tortuous retinal vessels (so-called "plus disease").
- Fibrovascular proliferation β traction bands.
- Partial/complete retinal detachment Β± foveal involvement.
π Screening & Investigations
- UK guidance: infants <32 weeks gestation or <1500 g birth weight β serial ophthalmology screening.
- First screening: usually by 4β6 weeks chronological age (or 31 weeks corrected gestation, whichever is later).
- Follow-up frequency depends on disease stage and risk.
- Fundoscopy with indirect ophthalmoscope is diagnostic.
π Management
- Prevention: Careful oxygen control in NICU (target sats 90β95%).
- Anti-VEGF injections (e.g. bevacizumab) β reduce neovascularisation.
- Laser photocoagulation β ablates avascular peripheral retina β β VEGF stimulus.
- Cryotherapy β historical, now rarely used.
- Vitrectomy for advanced disease/retinal detachment.
π Prognosis
- Mild cases may regress spontaneously.
- Advanced disease β tractional retinal detachment β irreversible blindness.
- Even with treatment, survivors may have strabismus, myopia, or amblyopia.
π References & Further Reading